z-logo
open-access-imgOpen Access
Treat and extend compared to pro re nata regimen in neovascular age-related macular degeneration
Author(s) -
Rodolfo Garretón
Publication year - 2020
Publication title -
medwave
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.178
H-Index - 7
ISSN - 0717-6384
DOI - 10.5867/medwave.2020.08.8023
Subject(s) - pro re nata , macular degeneration , medicine , regimen , peer review , optometry , ophthalmology , family medicine , gerontology , ranibizumab , bevacizumab , chemotherapy , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom